Te Ahumairangi Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.99M Sell
13,615
-1,339
-9% -$440K 0.67% 57
2025
Q4
$5.24M Sell
14,954
-2,050
-12% -$693K 0.94% 33
2025
Q3
$5.49M Buy
17,004
+804
+5% +$250K 0.93% 36
2025
Q2
$6.3M Buy
16,200
+4,830
+42% +$1.94M 1.13% 27
2025
Q1
$4.95M Sell
11,370
-650
-5% -$261K 1.05% 33
2024
Q4
$4.43M Buy
12,020
+1,512
+14% +$633K 0.93% 45
2024
Q3
$5.43M Buy
10,508
+2,983
+40% +$1.59M 0.96% 42
2024
Q2
$4.08M Sell
7,525
-368
-5% -$195K 0.78% 50
2024
Q1
$4.09M Buy
7,893
+2,665
+51% +$1.33M 0.71% 53
2023
Q4
$2.46M Buy
+5,228
New +$2.42M 0.47% 65

Other funds holding ELV

Te Ahumairangi Investment Management's ELV Position: Q1 2026 in Review

Te Ahumairangi Investment Management reduced its Elevance Health (ELV) stake by 9% in Q1 2026, selling an estimated $440K and leaving 13,615 shares worth $3.99M. The position accounts for 0.67% of the portfolio, ranked #57.

Te Ahumairangi Investment Management first reported a position in ELV in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.3M in Q2 2025. 1,466 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Te Ahumairangi Investment Management held 13,615 shares of Elevance Health worth $3.99M as of Q1 2026.
  • Te Ahumairangi Investment Management sold 1,339 Elevance Health shares in Q1 2026, an estimated $440K.
  • Elevance Health made up 0.67% of Te Ahumairangi Investment Management's portfolio in Q1 2026, its #57 holding.
  • Te Ahumairangi Investment Management first reported a position in Elevance Health in Q4 2023 and has held it in 10 quarters since.
  • Te Ahumairangi Investment Management's Elevance Health position peaked at $6.3M in Q2 2025.
  • 1,466 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Te Ahumairangi Investment Management's 13F filing for Q1 2026, filed 15 May 2026.